(Q46987541)
Statements
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience (English)
Raffaele Cozza
Ilaria Ilari
Luigi De Sio
Renata Boldrini
Alessandro Jenkner
Maretta De Ioris
Alessandro Inserra
Carlo Dominici
Alberto Donfrancesco